Robert W. Baird Reaffirms “Hold” Rating for Cardinal Health (CAH)

Robert W. Baird reaffirmed their hold rating on shares of Cardinal Health (NYSE:CAH) in a report issued on Wednesday morning. The brokerage currently has a $80.00 price target on the stock.

Other analysts have also issued reports about the stock. Cowen raised shares of Cardinal Health to a buy rating and set a $74.00 target price for the company in a research note on Tuesday, October 10th. Mizuho set a $70.00 target price on shares of Cardinal Health and gave the company a hold rating in a research note on Tuesday, October 24th. ValuEngine lowered shares of Cardinal Health from a buy rating to a hold rating in a research note on Sunday, December 31st. Evercore ISI assumed coverage on shares of Cardinal Health in a research note on Thursday, January 4th. They set an in-line rating and a $67.00 target price for the company. Finally, Jefferies Group cut their target price on shares of Cardinal Health from $77.00 to $67.00 and set a hold rating for the company in a research note on Tuesday, November 7th. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. Cardinal Health has a consensus rating of Hold and an average price target of $73.58.

Shares of Cardinal Health (NYSE CAH) opened at $71.91 on Wednesday. Cardinal Health has a one year low of $54.66 and a one year high of $84.88. The company has a market cap of $22,670.00, a P/E ratio of 20.97, a P/E/G ratio of 1.65 and a beta of 0.85. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period in the prior year, the business earned $1.24 earnings per share. The business’s quarterly revenue was up 1.9% on a year-over-year basis. equities analysts predict that Cardinal Health will post 5.12 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Monday, January 15th. Investors of record on Tuesday, January 2nd were given a $0.4624 dividend. The ex-dividend date of this dividend was Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.57%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.94%.

Large investors have recently modified their holdings of the stock. FDx Advisors Inc. lifted its position in shares of Cardinal Health by 7.9% in the 3rd quarter. FDx Advisors Inc. now owns 43,508 shares of the company’s stock valued at $2,912,000 after acquiring an additional 3,172 shares in the last quarter. Cadence Capital Management LLC lifted its position in shares of Cardinal Health by 8.4% in the 3rd quarter. Cadence Capital Management LLC now owns 65,205 shares of the company’s stock valued at $4,364,000 after acquiring an additional 5,078 shares in the last quarter. Janus Henderson Group PLC lifted its position in shares of Cardinal Health by 77.8% in the 3rd quarter. Janus Henderson Group PLC now owns 108,930 shares of the company’s stock valued at $7,291,000 after acquiring an additional 47,669 shares in the last quarter. Commonwealth Equity Services Inc lifted its position in shares of Cardinal Health by 7.4% in the 3rd quarter. Commonwealth Equity Services Inc now owns 72,959 shares of the company’s stock valued at $4,882,000 after acquiring an additional 5,011 shares in the last quarter. Finally, Teacher Retirement System of Texas lifted its position in shares of Cardinal Health by 4.6% in the 3rd quarter. Teacher Retirement System of Texas now owns 824,347 shares of the company’s stock valued at $55,165,000 after acquiring an additional 36,534 shares in the last quarter. Institutional investors and hedge funds own 88.36% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/20/robert-w-baird-reaffirms-hold-rating-for-cardinal-health-cah.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply